Solid lipid nanoparticles of clotrimazole silver complex: An efficient nano antibacterial against Staphylococcus aureus and MRSA

Colloids and Surfaces B: Biointerfaces

Volumn 136, Issue , 2015, Pages 651-658

  Kalhapure, Rahul S ^a   Sonawane, Sandeep J ^a   Sikwal, Dhiraj R ^a   Jadhav, Mahantesh ^a   Rambharose, Sanjeev ^a   Mocktar, Chunderika ^a   Govender, Thirumala ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Antibacterial; Clotrimazole; Resistant; Silver; Solid lipid nanoparticles; Staphylococcus aureus; Susceptible

Indexed keywords

ANTIBIOTICS; BACTERIA; CELL CULTURE; CELLS; CONTROLLED DRUG DELIVERY; MAMMALS; METAL COMPLEXES; MICROWAVE INTEGRATED CIRCUITS; NANOPARTICLES; SILVER; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY;

ANTIBACTERIAL; CLOTRIMAZOLE; RESISTANT; SOLID LIPID NANOPARTICLE (SLN); STAPHYLOCOCCUS AUREUS; SUSCEPTIBLE;

SILVER COMPOUNDS;

ANTIBIOTIC AGENT; CLOTRIMAZOLE; CLOTRIMAZOLE SILVER COMPLEX; METAL COMPLEX; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; LIPID; NANOPARTICLE; SILVER;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG SYNTHESIS; GEL ELECTROPHORESIS; HEPG2 CELL LINE; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; CHEMISTRY; DRUG EFFECTS; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CLOTRIMAZOLE; LIPIDS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; NANOPARTICLES; SILVER; STAPHYLOCOCCUS AUREUS;

EID: 84944735274     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2015.10.003     Document Type: Article

References (44)

1. Ravipaty S., Reilly J.P. Comprehensive characterization of methicillin-resistant Staphylococcus aureus subsp. aureus COL secretome by two-dimensional liquid chromatography and mass spectrometry. Mol. Cell Proteom. 2010, 9:1898-1919.
2. Chambers H.F., DeLeo F.R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 2009, 7:629-641.
3. Koch G., Yepes A., Förstner K.U., Wermser C., Stengel S.T., Modamio J., et al. Evolution of resistance to a last-resort antibiotic in Staphylococcus aureus via bacterial competition. Cell 2014, 158:1060-1071.
4. Egea A.L., Gagetti P., Lamberghini R., Faccone D., Lucero C., Vindel A., et al. New patterns of methicillin-resistant Staphylococcus aureus (MRSA) clones, community-associated MRSA genotypes behave like healthcare-associated MRSA genotypes within hospitals, Argentina. Int. J. Med. Microbiol. 2014, 304:1086-1099.
5. Horká M., Tesařová M., Karásek P., Růžička F., Holá V., Sittová M., et al. Determination of methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteria in blood by capillary zone electrophoresis. Anal. Chim. Acta 2015, 868:67-72.
6. Blair J.M.A., Webber M.A., Baylay A.J., Ogbolu D.O., Piddock L.J.V. Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol. 2015, 13:42-51.
7. Fair R.J., Tor Y. Antibiotics and bacterial resistance in the 21st Century. Perspect. Med. Chem. 2014, 6:25-64.
8. Kalhapure R.S., Suleman N., Mocktar C., Seedat N., Govender T. Nanoengineered drug delivery systems for enhancing antibiotic therapy. J. Pharm. Sci. 2015, 104:872-905.
9. Tonglairoum P., Ngawhirunpat T., Rojanarata T., Kaomongkolgit R., Opanasopit P. Fabrication of a novel scaffold of clotrimazole-microemulsion-containing nanofibers using an electrospinning process for oral candidiasis applications. Colloids Surf. B 2015, 126:18-25.
10. Das S., Ng W.K., Tan R.B.H. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?. Eur. J. Pharm. Sci. 2012, 47:139-151.
11. + transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J. Clin. Invest. 1993, 92:520-526.
12. Kast C.E., Valenta C., Leopold M., Bernkop-Schnürch A. Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole. J. Control Release 2002, 81:347-354.
13. Vazquez J.A. Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients. HIV Clin. Trials 2000, 1:47-59.
14. Yong C., Li D., Prabagar B., Park B., Yi S., Yoo B.-K., et al. The effect of β-cyclodextrin complexation on the bioavailability and hepatotoxicity of clotrimazole. Die Pharmazie 2007, 62:756-759.
15. Schaller K. In vitro antibacterial activity of different clotrimazole formulations. Chemother 1982, 28:32-36.
16. Suleman N., Kalhapure R.S., Mocktar C., Rambharose S., Singh M., Govender T. Silver salts of carboxylic acid terminated generation 1 poly (propyl ether imine) (PETIM) dendron and dendrimers as antimicrobial agents against S. aureus and MRSA. RSC Adv. 2015, 5:34967-34978.
17. Kalinowska-Lis U., Felczak A., Checinska L., Zawadzka K., Patnya E., Lisowska K., Ochocki J. Synthesis, characterization and antimicrobial activity of water-soluble silver (I) complexes of metronidazole drug and selected counter-ions. Dalton Trans. 2015, 44:8178-8189.
18. Huh A.J., Kwon Y.J. Nanoantibiotics: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J. Control Release 2011, 156:128-145.
19. Pelgrift R.Y., Friedman A.J. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv. Drug Deliv. Rev. 2013, 65:1803-1815.
20. Chernousova S., Epple M. Silver as antibacterial agent: ion, nanoparticle, and metal. Angew. Chem. Int. Ed. 2013, 52:1636-1653.
21. Kalhapure R.S., Mocktar C., Sikwal D.R., Sonawane S.J., Kathiravan M.K., Skelton A., et al. Ion pairing with linoleic acid simultaneously enhances encapsulation efficiency and antibacterial activity of vancomycin in solid lipid nanoparticles. Colloids Surf. B 2014, 117:303-311.
22. Sitohy M.Z., Mahgoub S.A., Osman A.O. In vitro and in situ antimicrobial action and mechanism of glycinin and its basic subunit. Int. J. Food Microbiol. 2012, 154:19-29.
23. Kalhapure R.S., Akamanchi K.G. A novel biocompatible bicephalous dianionic surfactant from oleic acid for solid lipid nanoparticles. Colloids Surf. B 2013, 105:215-222.
24. Malakar J., Nayak A.K. Formulation and statistical optimization of multiple-unit ibuprofen-loaded buoyant system using 23-factorial design. Chem. Eng. Res. Des. 2012, 90:1834-1846.
25. Siepmann J., Peppas N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Del. Rev. 2012, 64(Supplement):163-174.
26. Ciapetti G., Granchi D., Verri E., Savarino L., Cavedagna D., Pizzoferrato A. Application of a combination of neutral red and amido black staining for rapid, reliable cytotoxicity testing of biomaterials. Biomaterials 1996, 17:1259-1264.
27. Cao X.L., Cheng C., Ma Y.L., Zhao C.S. Preparation of silver nanoparticles with antimicrobial activities and the researches of their biocompatibilities. J. Mater. Sci. Mater. Med. 2010, 21:2861-2868.
28. Harisa G.I., Badran M.M. Simvastatin nanolipid carriers decreased hypercholesterolemia induced cholesterol inclusion and phosphatidylserine exposure on human erythrocytes. J. Mol. Liq. 2015, 208:202-210.
29. Souto E.B., Wissing S.A., Barbosa C.M., Müller R.H. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int. J. Pharm. 2004, 278:71-77.
30. El Maghraby G.M.M., Williams A.C., Barry B.W. Drug interaction and location in liposomes: correlation with polar surface areas. Int. J. Pharm. 2005, 292:179-185.
31. (accessed on 25.05.15). http://www.chemicalize.org.
32. Vueba M.L., Batista de Carvalho L.A.E., Veiga F., Sousa J.J., Pina M.E. Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets. Eur. J. Pharm. Biopharm. 2004, 58:51-59.
33. Yuksel N., Kanik A.E., Baykara T. Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methods. Int. J. Pharm. 2000, 209:57-67.
34. Betanzos-Lara S., Gómez-Ruiz C., Barrón-Sosa L.R., Gracia-Mora I., Flores-Álamo M., Barba-Behrens N. Cytotoxic copper(II), cobalt(II), zinc(II), and nickel(II) coordination compounds of clotrimazole. J. Inorg. Biochem. 2012, 114:82-93.
35. Rodrigues S., Dionísio M., López C.R., Grenha A. Biocompatibility of chitosan carriers with application in drug delivery. J. Funct. Biomater. 2012, 3:615-641.
36. Wilkening S., Stahl F., Bader A. Comparison of primary human hepatocytes and hepatoma cell line HepG2 with regard to their biotransformation properties. Drug Metab. Dispos. 2003, 31:1035-1042.
37. Kim S., Choi J.E., Choi J., Chung K.-H., Park K., Yi J., Ryu D.-Y. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol. In Vitro 2009, 23:1076-1084.
38. Gibbins B., Warner L. The role of antimicrobial silver nanotechnology. Med. Device Diagn. Ind. 2005, 1:1-2.
39. Mehrotra A., Nagarwal R.C., Pandit J.K. Lomustine loaded chitosan nanoparticles: characterization and in-vitro cytotoxicity on human lung cancer cell line L132. Chem. Pharm. Bull. 2011, 59:315-320.
40. Ojogun V.A., Lehmler H.-J., Knutson B.L. Cationic-anionic vesicle templating from fluorocarbon/fluorocarbon and hydrocarbon/fluorocarbon surfactants. J Colloids Interface Sci. 2009, 338:82-91.
41. Gao F., Cai Y., Zhou J., Xie X., Ouyang W., Zhang Y., et al. Pullulan acetate coated magnetite nanoparticles for hyper-thermia: preparation, characterization and in vitro experiments. Nano Res. 2010, 3:23-31.
42. Palm K., Stenberg P., Luthman K., Artursson P. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm. Res. 1997, 14:568-571.
43. Tronde A., Nordén B., Jeppsson A.-B., Brunmark P., Nilsson E., Lennernäs H., et al. Drug absorption from the isolated perfused rat lung-correlations with drug physicochemical properties and epithelial permeability. J. Drug Target 2003, 11:61-74.
44. Zur Mühlen A., Mehnert W. Drug release and release mechanism of prednisolone loaded solid lipid nanoparticles. Pharmazie 1998, 53:552-555.